United States Cell Regeneration Medicine Market 2025| Growth Drivers, Competitive Landscape, Key Players & Investment Opportunities

Market Size and Growth

The global cell regeneration medicine market reached US$ 34.3 billion in 2023 and is expected to reach US$ 90.1 billion by 2031, growing at a CAGR of 12.8% during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ In September 2025, Bayer advanced its Parkinson's disease cell therapy into Phase III trials. Developed by subsidiary BlueRock, the therapy aims to replace lost dopamine-producing neurons using stem cells. Bayer has invested approximately $250 million in a California-based production facility to support this initiative.

✅ In May 2025, Minaris Advanced Therapies launched as a global partner dedicated to cell therapy development, manufacturing, and testing. The company was formed through the merger of Minaris Regenerative Medicine and WuXi Advanced Therapies' U.S. and U.K. operations.

✅ In July 2025, Avant Technologies, Art-Islets, and Austrianova announced a joint venture to advance diabetes treatment. The collaboration focuses on developing encapsulated stem cell therapies for type 1 and insulin-dependent type 2 diabetes patients worldwide.

Japan: Recent Industry Developments

✅ In September 2025, CBRE facilitated Cellares' establishment of its first regenerative medicine development and manufacturing facility. Located within Mitsui Link-Lab Kashiwa-no-ha 2, the facility aims to advance cell therapy technologies.

✅ In July 2025, NKGen Biotech and HekaBio entered a strategic partnership to bring novel NK cell therapy to Japan. The collaboration focuses on expediting the regulatory, manufacturing, and commercial development of NKGen's autologous NK cell therapy, troculeucel, in Japan.

✅ In September 2025, JETRO launched the Japan Entry Acceleration Program (JEAP) 2025. The program supports international startups in regenerative medicine and cell therapy to accelerate their entry into the Japanese market through tailored mentorship and strategic networking.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cell-regeneration-medicine-market?sb

Cell Regeneration Medicine focuses on repairing or replacing damaged tissues and organs by stimulating cellular growth and regeneration. Utilizing stem cells, gene therapy, and tissue engineering, it aims to restore function, treat degenerative diseases, and advance regenerative healthcare solutions.

Recent Mergers and Acquisitions:

United States: Recent M&A Developments

✅ In August 2025, Gilead Sciences' Kite Pharma announced the acquisition of Interius BioTherapeutics for $350 million. This acquisition aims to enhance Kite's development of CAR T-cell therapies through Interius' novel in-vivo delivery platform, simplifying the treatment process.

✅ In March 2025, AstraZeneca entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies. The acquisition focuses on EsoBiotec's Engineered NanoBody Lentiviral (ENaBL) platform, which empowers the immune system to attack cancers.

✅ In April 2025, Shineco announced the acquisition of a Singapore-based evolutionary stem cell company. This move expands Shineco's capabilities in regenerative medicine, particularly in stem cell research and development.

Japan: Recent M&A Developments

✅ In April 2025, a Japanese company announced the acquisition of a Singapore-based evolutionary stem cell company. This strategic acquisition aims to bolster the company's regenerative medicine portfolio and expand its presence in the Asian market.

Key Players:

=> Astellas Pharma Inc, Thermo Fisher Scientific Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Stryker Corporation, Amgen Inc., F. Hoffmann, Roche Ltd, Baxter International Inc, Vertex Pharmaceuticals Incorporated and among others.

Growth Forecast Projected:

The Global cell regeneration medicine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global cell regeneration medicine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cell-regeneration-medicine-market

Key Segments:

➥ By Product Type: Cell-Based Products, Non-Cell-Based Products

➥ By Technology: Ex Vivo Culture, In Vivo Gene Modification, 3D Bioprinting, Nanotechnology, CRISPR and Genome Editing, Scaffold-Based Techniques

➥ By Application: Dermatology, Musculoskeletal, Immunology & Inflammation, Oncology, Cardiovascular, Ophthalmology, Others

➥ By End User: Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, Academic Institutes, Contract Research Organizations (CROs)

Regional Analysis for cell regeneration medicine Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among cell regeneration medicine producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze cell regeneration medicine revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cell-regeneration-medicine-market?sb

FAQ

What is the current size of the cell regeneration medicine Market?

A: In 2023, the cell regeneration medicine Market was valued at US$ 34.3 billion , reflecting its strong industry presence.

Q2: How large is the cell regeneration medicine Market expected to be by 2031?

A: By 2031, industry forecasts suggest the cell regeneration medicine Market will grow to around US$ 90.1 billion, demonstrating significant expansion.

Q3: What is the growth rate of the cell regeneration medicine Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.8% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.